Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Materials Companies: Lithium Americas Corp. (LAC) and IAMGOLD (IAG)

Tipranks - Tue Apr 7, 5:22AM CDT

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Lithium Americas Corp. (LAC) and IAMGOLD (IAG).

Easter Sale - 70% Off TipRanks

Lithium Americas Corp. (LAC)

In a report released yesterday, Bill Peterson from J.P. Morgan maintained a Hold rating on Lithium Americas Corp.. The company’s shares closed last Thursday at $4.04.

According to TipRanks.com, Peterson is a 3-star analyst with an average return of 2.8% and a 46.7% success rate. Peterson covers the Basic Materials sector, focusing on stocks such as Ivanhoe Electric Inc., Freeport-McMoRan, and Cleveland-Cliffs. ;'>

Currently, the analyst consensus on Lithium Americas Corp. is a Hold with an average price target of $6.07, a 59.3% upside from current levels. In a report issued on March 24, BMO Capital also reiterated a Hold rating on the stock with a $4.50 price target.

See the top stocks recommended by analysts >>

IAMGOLD (IAG)

Bank of America Securities analyst Lawson Winder reiterated a Buy rating on IAMGOLD yesterday and set a price target of $27.50. The company’s shares closed last Thursday at $19.09.

According to TipRanks.com, Winder is a 5-star analyst with an average return of 17.7% and a 58.2% success rate. Winder covers the Basic Materials sector, focusing on stocks such as Wheaton Precious Metals, Pan American Silver, and Nexa Resources SA. ;'>

Currently, the analyst consensus on IAMGOLD is a Strong Buy with an average price target of $26.24, representing a 44.4% upside. In a report issued on March 21, TipRanks – OpenAI also upgraded the stock to Buy with a C$25.00 price target.

Read More on LAC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.